Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
作者:
主题词
动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);细胞增殖(Cell Proliferation);细胞, 培养的(Cells, Cultured);纤维肉瘤(Fibrosarcoma);叉头转录因子类(Forkhead Transcription Factors);炎症介导素类(Inflammation Mediators);白细胞介素2(Interleukin-2);淋巴细胞活化(Lymphocyte Activation);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);甲基胆蒽(Methylcholanthrene);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 基因敲除(Mice, Knockout);表型(Phenotype);肉瘤, 实验性(Sarcoma, Experimental);信号传导(Signal Transduction);T盒域蛋白质类(T-Box Domain Proteins);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);Th1细胞(Th1 Cells);肿瘤微环境(Tumor Microenvironment)
DOI
10.18632/oncotarget.5584
PMID
26433463
发布时间
2022-01-29
- 浏览82

Oncotarget
24649-59页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文